Records 1 - 4
| PPARG c.1347C>T polymorphism is associated with cancer susceptibility: from a case-control study to a meta-analysis.
Oncotarget 2017 Nov 8 (60): 102277-102290.
Ding Hao, Chen Yuanmei, Qiu Hao, Liu Chao, Wang Yafeng, Kang Mingqiang, Tang Weife
| Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers.
Lung cancer (Amsterdam, Netherlands) 2014 Sep 85 (3): 449-56.
Yang Ying, Burke Rita V, Jeon Christie Y, Chang Shen-Chih, Chang Po-Yin, Morgenstern Hal, Tashkin Donald P, Mao Jenny, Cozen Wendy, Mack Thomas M, Rao Jianyu, Zhang Zuo-Fe
| Association between the peroxisome proliferator-activated receptor gamma Pro12Ala variant and haplotype and pancreatic cancer in a high-risk cohort of smokers: a pilot study.
Pancreas 2009 Aug 38 (6): 631-7.
Fesinmeyer Megan Dann, Stanford Janet L, Brentnall Teresa A, Mandelson Margaret T, Farin Federico M, Srinouanprachanh Sengkeo, Afsharinejad Zahra, Goodman Gary E, Barnett Matt J, Austin Melissa
| Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer.
Carcinogenesis 2004 Feb 25 (2): 229-35.
Campa Daniele, Zienolddiny Shanbeh, Maggini Valentina, Skaug Vidar, Haugen Aage, Canzian Federi